United States · FDA National Drug Code directory

amiodarone hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68382-227_b3f11ad6-9f3b-4054-9c51-3d2614c1002e
Product NDC
68382-227
Form
TABLET
Composition / generic term
amiodarone hydrochloride
Labeler
Zydus Pharmaceuticals USA Inc.
Marketing category
ANDA
Marketing start / end (source format)
20090810
Source listing expiry
20261231

Source-listed ingredients

  • AMIODARONE HYDROCHLORIDE — 200 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 500 TABLET in 1 BOTTLE (68382-227-05) · 68382-227-05
  • 30 TABLET in 1 BOTTLE (68382-227-06) · 68382-227-06
  • 1000 TABLET in 1 BOTTLE (68382-227-10) · 68382-227-10
  • 60 TABLET in 1 BOTTLE (68382-227-14) · 68382-227-14
  • 100 BLISTER PACK in 1 CARTON (68382-227-77) / 1 TABLET in 1 BLISTER PACK (68382-227-30) · 68382-227-77

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →